Table of Contents

company-logo

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California.

aTyr Pharma Dividend Announcement

• aTyr Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on aTyr Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

aTyr Pharma Dividend History

aTyr Pharma Dividend Yield

aTyr Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing aTyr Pharma stock? Use our calculator to estimate your expected dividend yield:

aTyr Pharma Financial Ratios

P/E ratio-2.33
PEG ratio0.52
P/B ratio1.49
ROE-56.83%
Payout ratio0.00%
Current ratio6.07
Quick ratio6.07
Cash Ratio0.43

aTyr Pharma Dividend FAQ

Does aTyr Pharma stock pay dividends?
aTyr Pharma does not currently pay dividends to its shareholders.
Has aTyr Pharma ever paid a dividend?
No, aTyr Pharma has no a history of paying dividends to its shareholders. aTyr Pharma is not known for its dividend payments.
Why doesn't aTyr Pharma pay dividends?
There are several potential reasons why aTyr Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will aTyr Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While aTyr Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is aTyr Pharma a dividend aristocrat?
aTyr Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is aTyr Pharma a dividend king?
aTyr Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is aTyr Pharma a dividend stock?
No, aTyr Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy aTyr Pharma stocks?
To buy aTyr Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy aTyr Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.